Medical News: ASCO GI: Mixed Results for Liposomal Irinotecan - in Meeting Coverage, ASCO GI from MedPage Today
Links shared publicly online about this topic.
- 561total visits
Medical News: ASCO GI: Mixed Results for Liposomal Irinotecan - in Meeting Coverage, ASCO GI from MedPage Today
SAN FRANCISCO -- A randomized trial of liposomal irinotecan (PEP02) in gastric cancer yielded mixed results, achieving the primary objective of tumor shrinkage but without improving disease control ra
View full resource at medpagetoday.com
Tags: Gastroenterology, Cancer, Colorectal Cancer Medication, Stomach Cancer, Camptosar, News, disease, Medical
Most Recently Shared on January 23, 2011 at 2:40 am By:
ASCO GI: Mixed Results for Liposomal Irinotecan http://bit.ly/gLsoWU
Medical News: ASCO GI: Mixed Results for Liposomal Irinotecan - in Meeting Coverage, ASCO GI from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- A randomized trial of liposomal irinotecan (PEP02) in gastric cancer yielded mixed results, achieving the primary objective of tumor shrinkage but without improving disease control ra” View full resource at medpagetoday.com
Most Recently Shared on January 23, 2011 at 3:19 am By:
ASCO GI: Mixed Results for Liposomal Irinotecan http://bit.ly/ffcOhR
Advertisement
